FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387207710> ?p ?o ?g. }

• W4387207710 endingPage "S64" @default.
• W4387207710 startingPage "S64" @default.
• W4387207710 abstract "Our group has recently published its long-term experience treating gastric MALT lymphomas with involved site radiation therapy (ISRT) and supported the use of RT alone as standard of care for H pylori independent MALT. For primary gastric (PG) diffuse large B-cell lymphomas (DLBCL), R-CHOP is the mainstay of therapy, but RT to the stomach primarily as consolidation has rarely been analyzed. In this study, we focus on pts with PG DLBCL who received combined modality therapy.Two hundred eighty-five consecutive pts with PG lymphomas treated with RT between January 2000 and January 2021 at our institution were retrospectively identified. Baseline characteristics and follow-up data were abstracted. Overall response rate (ORR) was assessed with Lugano PET criteria and endoscopy. Overall survival (OS) was calculated using Kaplan-Meier. Toxicity was assessed with CTCAE version 4.0.Of 285 pts, 203 (71%) had PG MALT and 82 (29%) PG DLBCL. Baseline characteristics are summarized in Table 1. In the DLBCL pts, 74 (90%) received consolidation RT after limited (3-4 cycles) or full (6 cycles) chemoimmunotherapy (CT), 4 (5%) received RT after 2 lines of CT, 2 (3%) received first line RT followed by CT, 1 (1%) had 3 lines of CT and RT, and 1 (1%) was treated with surgery, 2 lines of CT, and RT. In the 74 pts who received CT+RT as first line treatment, the median RT dose was 3060 cGy (range 1620-3600). Based on post-chemo pre-RT EGD and PET, 61 (82%) pts were in CR, 7 (10%) had PR, 3 (4%) had SD and 3 (4%) pts were not assessed. Overall, 66 (89%) pts who received RT after CT achieved a CR. Of the remaining 8 (11%) pts who did not achieve a CR after RT, 4 had PR, 1 had SD, 1 was lost to FU, 1 started additional CT before response assessment and 1 pt died. The 2 pts in the DLBCL group who received first line RT achieved CR after RT. Side effects after RT were mild and limited to nausea and fatigue. The median follow-up time was 5.4 yrs (95% CI 0.4, 20.4) in DLBCL pts and 6.3 yrs (95% CI 0.3, 22.1) in MALT pts. The 5-yr OS was 80% (95% CI 71-90%) for DLBCL and 96% (95% CI 93-99%) for MALT.Adding stomach RT following chemoimmunotherapy is feasible, well-tolerated and safe. More in depth analysis PG DLBCL is underway, with a plan to compare outcomes of patients treated with CT alone versus CT followed by RT, and further analyze treatment-related toxicities, progression-free survival, and patterns of recurrence." @default.
• W4387207710 created "2023-09-30" @default.
• W4387207710 creator A5007588773 @default.
• W4387207710 creator A5023759382 @default.
• W4387207710 creator A5054664737 @default.
• W4387207710 creator A5057053281 @default.
• W4387207710 creator A5062047796 @default.
• W4387207710 creator A5074971164 @default.
• W4387207710 creator A5092127716 @default.
• W4387207710 date "2023-10-01" @default.
• W4387207710 modified "2023-10-17" @default.
• W4387207710 title "Radiation Therapy in the Management of Primary Gastric Diffuse Large B-Cell Lymphomas: Long-Term Outcomes of 82 Patients" @default.
• W4387207710 doi "https://doi.org/10.1016/j.ijrobp.2023.06.365" @default.
• W4387207710 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37784544" @default.
• W4387207710 hasPublicationYear "2023" @default.
• W4387207710 type Work @default.
• W4387207710 citedByCount "0" @default.
• W4387207710 crossrefType "journal-article" @default.
• W4387207710 hasAuthorship W4387207710A5007588773 @default.
• W4387207710 hasAuthorship W4387207710A5023759382 @default.
• W4387207710 hasAuthorship W4387207710A5054664737 @default.
• W4387207710 hasAuthorship W4387207710A5057053281 @default.
• W4387207710 hasAuthorship W4387207710A5062047796 @default.
• W4387207710 hasAuthorship W4387207710A5074971164 @default.
• W4387207710 hasAuthorship W4387207710A5092127716 @default.
• W4387207710 hasConcept C126322002 @default.
• W4387207710 hasConcept C126838900 @default.
• W4387207710 hasConcept C141071460 @default.
• W4387207710 hasConcept C143998085 @default.
• W4387207710 hasConcept C2778559949 @default.
• W4387207710 hasConcept C2779338263 @default.
• W4387207710 hasConcept C2780653079 @default.
• W4387207710 hasConcept C2780790343 @default.
• W4387207710 hasConcept C2989005 @default.
• W4387207710 hasConcept C509974204 @default.
• W4387207710 hasConcept C71924100 @default.
• W4387207710 hasConcept C90924648 @default.
• W4387207710 hasConceptScore W4387207710C126322002 @default.
• W4387207710 hasConceptScore W4387207710C126838900 @default.
• W4387207710 hasConceptScore W4387207710C141071460 @default.
• W4387207710 hasConceptScore W4387207710C143998085 @default.
• W4387207710 hasConceptScore W4387207710C2778559949 @default.
• W4387207710 hasConceptScore W4387207710C2779338263 @default.
• W4387207710 hasConceptScore W4387207710C2780653079 @default.
• W4387207710 hasConceptScore W4387207710C2780790343 @default.
• W4387207710 hasConceptScore W4387207710C2989005 @default.
• W4387207710 hasConceptScore W4387207710C509974204 @default.
• W4387207710 hasConceptScore W4387207710C71924100 @default.
• W4387207710 hasConceptScore W4387207710C90924648 @default.
• W4387207710 hasIssue "2" @default.
• W4387207710 hasLocation W43872077101 @default.
• W4387207710 hasLocation W43872077102 @default.
• W4387207710 hasOpenAccess W4387207710 @default.
• W4387207710 hasPrimaryLocation W43872077101 @default.
• W4387207710 hasRelatedWork W1598567296 @default.
• W4387207710 hasRelatedWork W1996279342 @default.
• W4387207710 hasRelatedWork W2011070553 @default.
• W4387207710 hasRelatedWork W2102241654 @default.
• W4387207710 hasRelatedWork W2152012720 @default.
• W4387207710 hasRelatedWork W2272592620 @default.
• W4387207710 hasRelatedWork W2403773722 @default.
• W4387207710 hasRelatedWork W2899246565 @default.
• W4387207710 hasRelatedWork W2943135325 @default.
• W4387207710 hasRelatedWork W3036493517 @default.
• W4387207710 hasVolume "117" @default.
• W4387207710 isParatext "false" @default.
• W4387207710 isRetracted "false" @default.
• W4387207710 workType "article" @default.